Division Chief, Multiple Myeloma
David Siegel, M.D., Ph.D., chief of the Division of Multiple Myeloma, is one of the nation’s foremost authorities on multiple myeloma. Most recently, Dr. Siegel served the lead investigator of the pivotal multi-center, phase IIb study involving 30 cancer centers in North America that led to the FDA’s fast-track approval of Kyprolis (carfilzomib) for relapsed multiple myeloma patients.
years treating myeloma: Unknown
Number of Myeloma Patients Treated Annually: Unknown
Details & contact info
92 2nd Street
Hackensack, New Jersey, United States, 7601
Phone: (201) 257-5041